BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20580889)

  • 21. Congenital portosystemic shunts in dogs: 46 cases (1979-1986).
    Johnson CA; Armstrong PJ; Hauptman JG
    J Am Vet Med Assoc; 1987 Dec; 191(11):1478-83. PubMed ID: 3693002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboelastographic evaluation of dogs with congenital portosystemic shunts.
    Kelley D; Lester C; DeLaforcade A; Webster CR
    J Vet Intern Med; 2013; 27(5):1262-7. PubMed ID: 23815243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostatic profiles in 39 dogs with congenital portosystemic shunts.
    Niles JD; Williams JM; Cripps PJ
    Vet Surg; 2001; 30(1):97-104. PubMed ID: 11172465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Giant platelet disorder in the Cavalier King Charles Spaniel.
    Cowan SM; Bartges JW; Gompf RE; Hayes JR; Moyers TD; Snider CC; Gerard DA; Craft RM; Muenchen RA; Carroll RC
    Exp Hematol; 2004 Apr; 32(4):344-50. PubMed ID: 15050744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity.
    Hernandez MR; Tonda R; Pedreño J; Salas E; Arderiu G; Pino M; Serradell M; Escolar G
    J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):859-65. PubMed ID: 17122671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of adenosine 5'-diphosphate (ADP)- and collagen-induced platelet aggregation in canine leishmaniasis.
    Pelagalli A; Ciaramella P; Lombardi P; Pero ME; Cortese L; Corona M; Oliva G; Avallone L
    J Comp Pathol; 2004; 130(2-3):124-9. PubMed ID: 15003469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal function and thromboxane release from platelets of dogs with cyclic hematopoiesis.
    Boney CM; McDonald TP; Jones JB
    Exp Hematol; 1985 Jul; 13(6):586-90. PubMed ID: 3996494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effect of blood cell counts on multiple-electrode impedance aggregometry in dogs.
    Nash KJ; Bacek LM; Christopherson PW; Spangler EA
    Am J Vet Res; 2017 Dec; 78(12):1380-1386. PubMed ID: 29182390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation profiles in dogs with congenital portosystemic shunts before and after surgical attenuation.
    Kummeling A; Teske E; Rothuizen J; Van Sluijs FJ
    J Vet Intern Med; 2006; 20(6):1319-26. PubMed ID: 17186844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
    Nimmerfall K; Mischke R
    Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of diagnostic importance of platelet closure times measured by Platelet Function Analyzer--PFA 100 in dogs with endotoxemia.
    Yilmaz Z; Ilcol YO; Ulus IH
    Berl Munch Tierarztl Wochenschr; 2005; 118(7-8):341-8. PubMed ID: 16048047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of the haematocrit on primary haemostasis in vitro.
    Eugster M; Reinhart WH
    Thromb Haemost; 2005 Dec; 94(6):1213-8. PubMed ID: 16411396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in platelet function in Dachshunds with early stages of myxomatous mitral valve disease.
    Moesgaard SG; Sørensen TM; Sterup A; Tarnow I; Kristensen AT; Jensen AL; Olsen LH
    Res Vet Sci; 2009 Apr; 86(2):320-4. PubMed ID: 18789461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of platelet function in dogs with cardiac disease using the PFA-100 platelet function analyzer.
    Clancey N; Burton S; Horney B; Mackenzie A; Nicastro A; Côté E
    Vet Clin Pathol; 2009 Sep; 38(3):299-305. PubMed ID: 19392759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts.
    Aronson LR; Gacad RC; Kaminsky-Russ K; Gregory CR; Mullen KD
    Vet Surg; 1997; 26(3):189-94. PubMed ID: 9150556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function tests in childhood. Measuring aggregation and release reaction in whole blood.
    Knöfler R; Weissbach G; Kuhlisch E
    Semin Thromb Hemost; 1998; 24(6):513-21. PubMed ID: 10066146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-blood platelet aggregation, buccal mucosa bleeding time, and serum cephalothin concentration in dogs receiving a presurgical antibiotic protocol.
    Schermerhorn T; Barr SC; Stoffregen DA; Koren-Roth Y; Erb HN
    Am J Vet Res; 1994 Nov; 55(11):1602-7. PubMed ID: 7879986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and clinical application of platelet function testing in small animal practice.
    Christopherson PW; Spangler EA; Boudreaux MK
    Vet Clin North Am Small Anim Pract; 2012 Jan; 42(1):173-88. PubMed ID: 22285164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole blood manganese concentrations in dogs with congenital portosystemic shunts.
    Gow AG; Marques AI; Yool DA; Duncan A; Mellanby RJ
    J Vet Intern Med; 2010; 24(1):90-6. PubMed ID: 19912521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.